Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL

Clinical trial NCT00981799 · TERMINATED

Trial details

NCT number: NCT00981799
Sponsor: Therapeutic Advances in Childhood Leukemia Consortium
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Relapsed T-Cell Acute Lymphoblastic Leukemia Relapsed T-Cell Lymphoblastic Lymphoma

Start date: 2010-06-01
Primary completion: 2015-11-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.